Investigator(s):
The Lundquist Institute
At one point in our lives we have all heard genes play a large part in our destiny. Yet we have seen or heard of identical twins who have gone to live extremely different lives. It is quite evident that our genes aren’t everything. Indeed the unprecedentedly increasing rates of obesity and diabetes in Australia clearly demonstrate that our choices in diet and sedentary lifestyles are impacting our health.
Investigator(s):
The Lundquist Institute
Medical Daily
By Peter Sergo | Oct 24, 2013 07:23 PM EDT
In 1945, Alexander Fleming, the discoverer of penicillin, already noticed bacteria’s ominous ability to acquire resistance to the antibiotic that saved so many lives. At the time, he even warned that overuse of penicillin would lead to more people dying from infections that are impervious to the revolutionary treatment.
Investigator(s):
The Lundquist Institute
$6.4 Million Grant Funds Study Glaucoma in African-Americans
A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.
Investigator(s):
The Lundquist Institute
By Sandy Mazza, Daily Breeze
Posted: 10/12/13, 2:55 PM PDT | Updated: on 10/14/2013
Lisa Lancaster drove an old car and wore modest clothes to the Inglewood office where she spent two decades administering nutritional and health aid to low-income women and children.
NovaDigm Therapeutics Raises $14M Series B to Support Phase 2 Trial of NDV-3 Vaccine Against Candida
Investigator(s):
The Lundquist Institute
4-traders
10/03/2013 | 08:31am US/Eastern
Investigator(s):
The Lundquist Institute
A team of researchers will use state-of-the-art brain imaging to unlock the secrets of a genetic disease, mucopolysaccharidosis (MPS), in a landmark study the team hopes will lead to new treatments for this devastating disease.
Investigator(s):
The Lundquist Institute
The Scientist
By Tracy Vence | September 25, 2013
Employing a treatment framework in which clinicians administer different drugs in strategic succession could both treat bacterial infections and select against the development of resistance, Technical University of Denmark’s Lejla Imamovic and Morten Sommer argue today (September 25) in Science Translational Medicine. This new framework, which the researchers call collateral sensitivity cycling, could also help curb unnecessary antibiotic use, which is known to contribute to the emergence of drug-resistant superbugs.
Investigator(s):
Mina Desai, PhD, Michael Ross, MD, MPH
While much of the obesity prevention efforts today focus on diet and exercise, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) researchers are going even further back in time to explore what happens during development in the womb that could lead to overeating and obesity later in life.
Michael G. Ross, MD, MPH, and Mina Desai, M.Sc., PhD, both LA BioMed lead investigators, recently received two grants to further their studies into influences on fetal development that can cause obesity.
Investigator(s):
The Lundquist Institute
Paula R. Moore, the former executive director of the FRIENDS of Cabrillo Marine Aquarium, a nonprofit organization that supports the San Pedro-based aquarium, will be joining the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) on Aug. 26 as the director of development.
Investigator(s):
The Lundquist Institute
LOS ANGELES – (August 5, 2013) – With some 300 million people around the world living with asthma, a study by Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) researchers that was released ahead-of-print found for the first time that maternal smoking can cause the third generation of offspring to suffer from the chronic lung disease.